Literature DB >> 10543745

Diversity of TEM mutants in Proteus mirabilis.

R Bonnet1, C De Champs, D Sirot, C Chanal, R Labia, J Sirot.   

Abstract

In a survey of resistance to amoxicillin among clinical isolates of Proteus mirabilis, 10 TEM-type beta-lactamases were characterized: (i) the well-known penicillinases TEM-1 and TEM-2, the extended-spectrum beta-lactamases (ESBLs) TEM-3 and TEM-24, and the inhibitor-resistant TEM (IRT) TEM-44 and (ii) five novel enzymes, a penicillinase TEM-57 similar to TEM-1, an ESBL TEM-66 similar to TEM-3, and three IRTs, TEM-65, TEM-73, and TEM-74. The penicillinase TEM-57 and the ESBL TEM-66 differed from TEM-1 and TEM-3, respectively, by the amino acid substitution Gly-92-->Asp (nucleotide mutation G-477-->A). This substitution could have accounted for the decrease in pIs (5.2 for TEM-57 and 6.0 for TEM-66) but did not necessarily affect the intrinsic activities of these enzymes. The IRT TEM-65 was an IRT-1-like IRT (Cys-244) related to TEM-2 (Lys-39). The two other IRTs, TEM-73 and TEM-74, were related to IRT-1 (Cys-244) and IRT-2 (Ser-244), respectively, and harbored the amino acid substitutions Leu-21-->Phe and Thr-265-->Met. In this study, the ESBLs TEM-66, TEM-24, and TEM-3 were encoded by large (170- to 180-kb) conjugative plasmids that exhibited similar patterns after digestion and hybridization with the TEM and AAC(6')I probes. The three IRTs TEM-65, TEM-73, and TEM-74 were encoded by plasmids that ranged in size from 42 to 70 kb but for which no transfer was obtained. The characterization of five new plasmid-mediated TEM-type beta-lactamases and the first report of TEM-24 in P. mirabilis are evidence of the wide diversity of beta-lactamases produced in this species and of its possible role as a beta-lactamase-encoding plasmid reservoir.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543745      PMCID: PMC89541     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Plasmid-determined beta-lactamase indistinguishable from the chromosomal beta-lactamase of Escherichia coli.

Authors:  M M Bobrowski; M Matthew; P T Barth; N Datta; N J Grinter; A E Jacob; P Kontomichalou; J W Dale; J T Smith
Journal:  J Bacteriol       Date:  1976-01       Impact factor: 3.490

2.  Properties of plasmids responsible for production of extended-spectrum beta-lactamases.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis.

Authors:  C Verdet; G Arlet; S Ben Redjeb; A Ben Hassen; P H Lagrange; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1998-12-15       Impact factor: 2.742

4.  Mechanisms of hyperproduction of TEM-1 beta-lactamase by clinical isolates of Escherichia coli.

Authors:  P J Wu; K Shannon; I Phillips
Journal:  J Antimicrob Chemother       Date:  1995-12       Impact factor: 5.790

5.  Molecular diversity and evolution of blaTEM genes encoding beta-lactamases resistant to clavulanic acid in clinical E. coli.

Authors:  M M Caniça; C Y Lu; R Krishnamoorthy; G C Paul
Journal:  J Mol Evol       Date:  1997-01       Impact factor: 2.395

6.  Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of beta-lactamase in Pseudomonas aeruginosa and Escherichia coli.

Authors:  S T Chen; R C Clowes
Journal:  J Bacteriol       Date:  1987-02       Impact factor: 3.490

Review 7.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

8.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

Authors:  D Sirot; J Sirot; R Labia; A Morand; P Courvalin; A Darfeuille-Michaud; R Perroux; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

9.  Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids.

Authors:  C M Chanal; D L Sirot; A Petit; R Labia; A Morand; J L Sirot; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.

Authors:  G Vedel; A Belaaouaj; L Gilly; R Labia; A Philippon; P Névot; G Paul
Journal:  J Antimicrob Chemother       Date:  1992-10       Impact factor: 5.790

View more
  27 in total

1.  New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates.

Authors:  C de Champs; C Monne; R Bonnet; W Sougakoff; D Sirot; C Chanal; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group.

Authors:  C De Champs; D Sirot; C Chanal; R Bonnet; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

3.  TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.

Authors:  C Neuwirth; S Madec; E Siebor; A Pechinot; J M Duez; M Pruneaux; M Fouchereau-Peron; A Kazmierczak; R Labia
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

4.  Evolution of TEM-related extended-spectrum beta-lactamases in Korea.

Authors:  H Pai; H J Lee; E H Choi; J Kim; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Sequences of the NPS-1 and TLE-1 beta-lactamase genes.

Authors:  H Pai; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

6.  Emerging extended-spectrum beta-lactamases in Proteus mirabilis.

Authors:  Laura Pagani; Roberta Migliavacca; Lucia Pallecchi; Cecilia Matti; Ernesto Giacobone; Gianfranco Amicosante; Egidio Romero; Gian Maria Rossolini
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 7.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

8.  Inducible AmpC beta-lactamase of a new member Enterobacteriaceae.

Authors:  Richard Bonnet; Catherine Chanal; Elisabeth Ageron; Danielle Sirot; Christophe De Champs; Patrick Grimont; Jacques Sirot
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

9.  Quantifying nonspecific TEM beta-lactamase (blaTEM) genes in a wastewater stream.

Authors:  Karen L Lachmayr; Lee J Kerkhof; A Gregory Dirienzo; Colleen M Cavanaugh; Timothy E Ford
Journal:  Appl Environ Microbiol       Date:  2008-11-07       Impact factor: 4.792

10.  Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase.

Authors:  Noriyuki Nagano; Naohiro Shibata; Yuko Saitou; Yukiko Nagano; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.